Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
| ▸ | MET | P08581 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8371507 | 1.00 | HIF1A (0.67) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL6460031 | 1.00 | HIF1A (0.67) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8620470 | 0.90 | HIF1A (0.55) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8620469 | 0.90 | HIF1A (0.55) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8396210 | 0.90 | HIF1A (0.65) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8396217 | 0.90 | HIF1A (0.65) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8617320 | 0.90 | HIF1A (0.66) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8617317 | 0.90 | HIF1A (0.66) | HIF1AMCL1MRGPRX4KDM4EMAOB | |
| SCHEMBL8369843 | 0.89 | HIF1A (0.59) | HIF1AMRGPRX4MAOB | |
| SCHEMBL8618334 | 0.89 | HIF1A (0.67) | HIF1AMCL1MRGPRX4KDM4EMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030055096-A1 | Fungicidal composition | OGURI YUKIO (JP) | 2003-03-20 | — | — | US | claimed |
| EP-0741970-A1 | BACTERICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-11-13 | — | — | EP | claimed |
| US-6838482-B2 | Fungicidal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-01-04 | — | — | US | disclosed |
| US-20030055096-A1 | Fungicidal composition | OGURI YUKIO (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-0644183-B1 | Process of producing N-alkylacetamides | SHIONOGI & CO (JP) | 1999-06-02 | — | — | EP | disclosed |
| EP-0658541-B1 | PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE | SHIONOGI & CO (JP) | 1998-05-20 | — | — | EP | disclosed |
| EP-0741970-A1 | BACTERICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-11-13 | — | — | EP | disclosed |
| EP-0737421-A1 | BACTERICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-10-16 | — | — | EP | disclosed |
| US-5510506-A | Process for producing carboxylic acid derivatives | SHIONOGI & CO., LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| US-5498792-A | Process of producing N-alkylacetamides | SHIONOGI & CO., LTD. (JP) | 1996-03-12 | — | — | US | disclosed |
| EP-0658541-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 1995-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055096-A1 | Fungicidal composition | CBR1, CBR3, CYP1B1 | HIF1A 2640/4885MCL1 2149/4885MRGPRX4 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.